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A B S T R A C T
Acute and long-term sequels of central nervous system (CNS) prophylaxis with irra-
diation and intrathecal chemotherapy in children suffering from acute lymphoblastic
leukemia (ALL) include vasculopathies, leucoencephalopathies, intracranial calcificati-
ons, intellectual and neurological impairment. We report two children at the age 5 and 8
years who manifested partial motor or complex seizures and intracranial calcifications
2–4 years after the diagnosis of ALL had been established. The occurrence of these disor-
ders was much earlier than reported in the literature. Both children received prophylac-
tic CNS treatment with irradiation and intrathecal methotrexate (MTX). Their brain
CT scans and EEG had been normal before the first epileptic seizure was registered.
Children are now seizure free on carbamazepine, and a boy with complex partial and
myoclonic seizures is also on valproate and vigabatrine. Symptomatic epilepsy associ-
ated with intracranial calcifications and persisting EEG changes might occur as side
effects of ALL treatment.
Introduction
Acute and long-term sequels of the
central nervous system (CNS) prophyla-
xis with irradiation and intrathecal che-
motherapy in children include leucoen-
cephalopathy and necrotising encephalo-
pathy or microangiopathy associated
with different intellectual and neurologi-
cal impairment1–4. Areas of demyelinisa-
tion, axonal swelling, necrosis and cal-
cifications are found on brain autopsy5.
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Although the doses used in prophylactic
cranial irradiation are much below the
doses causing morphological injury5,6,
even low doses are able to produce EEG
changes7. Methotrexate is the folic acid
antagonist interfering with myelin me-
tabolism constituents. Chronic methotre-
xate encephalopathy presents occasion-
ally with epileptic seizures and intracra-
nial calcifications8. No correlation could
be established between neurological ab-
normalities and CT findings that are
found in 53% of ALL children after pro-
phylactic CNS treatment with irradiation
and intrathecal chemotherapy1,3. Post ir-
radiation syndrome might be a predictor
of the development of late neurological
sequels in children with ALL. We report
two children who manifested recurrent
epileptic seizures and intracranial cal-
cifications 2–4 years after the diagnosis
of ALL had been established.
Case 1
S.I., is a boy who was at the age of 5.5
years admitted to hospital because of his
first epileptic seizure associated with
right hemiparesis postictally. He was
born after pregnancy during which his
mother had been operated for cerebral
aneurysm, and her CT scans had been
performed in the 7th month of gestational
age. The diagnosis of acute lymphoblastic
leukemia was established at the age of
2.5 years. He was treated with intrathe-
cal methotrexate (MTX 8 mg 10 on days
1, 14, 16, 18, 20, 22 and four times during
maintenance therapy every three
months) + cytosine arabinoside (30 mg/
m2). The Vehicle used for intrathecal the-
rapy was 0.9% NaCl. Three months prior
to the admission he had been in complete
hematological and clinical remission and
his first EEG had been normal. On ad-
mission he was somnolent, with right
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Fig. 1. S.I., 5.5 yrs.; Asymmetrical abnormality with continuous slow













spastic hemiparesis which resolved after
two days. His EEG showed asymmetrical
abnormality with continuous slow activ-
ity above the left hemisphere (Figure 1).
His brain CT-scan was normal at that
time. One month later he developed clini-
cal and radiological signs of CNS leuke-
mia. Relapses in CNS were treated with
systemic chemotherapy, intrathecal MTX
(8  12 mg MTX) and CNS irradiation
(the brain and cervical spine were irradi-
ated with 2000 cGy divided in 14 daily
doses). He manifested recurrent epileptic
seizures at the age of 6.6 years. Control
brain CT-scans at the age of 7.5 years
showed intracerebral calcifications in the
periventricular white matter (Figure 2).
He is now seizure free on carbamazepine
treatment, exhibiting normal psychomo-
tor development.
Case 2
S.D., an 8-year-old boy, was admitted
to hospital because of 2 partial complex
seizures. Diagnosis of ALL was establis-
hed at the age of 1.5 years and he re-
ceived CNS irradiation (the brain and
three upper parts of cervical spine were
irradiated with 2000 cGy divided in 14
daily doses). Intrathecal methotrexate
was given 9 times (MTX 8 mg on days 1,
14, 16, 18, 20, 22 and three times during
maintenance therapy every three months).
The vehicle used for intrathecal therapy
was 0.9% NaCl. He had been in complete
clinical and hematological remission two
years prior to the seizures. His first EEG,
made before the first seizures occurred,
had been normal as well as the EEG
made one year afterwards on follow-up.
His CT scan had revealed gyriform in-
tracerebral calcifications, which remai-
ned unchanged on the recently performed
control brain CT-scan. He was treated
with valproic acid, and carbamazepine.
Besides complex partial seizures, he also
manifested complex absence of seizures.
His EEG at the time of therapy with
valproate and carbamazepine showed in-
tensive focal as well as extensive paroxys-
mal discharges (Figure 3). Ethosuximide
in combination with valproic acid was in-
troduced without positive therapeutic ef-
fects. Vigabatrine (Sabril) was introduced
together with valproic acid at the age of
11 years. He is seizure free for the last 3
years and he has normal mental develop-
ment. EEG recording for the last two
years is completely normal.
Discussion
We observed persistent EEG abnor-
malities 2–4 years after induction of clini-
cal and hematological remission in two
children with ALL who received CNS ir-
radiation/MTX treatment. CT scan and
EEG were normal in both of them during
the ALL treatment Diffuse EEG changes
during induction/reinduction treatment
or CNS irradiation are usually transient.
They are mostly associated with acute
neurotoxic side effects of chemotherape-
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Fig. 2. S.I., 5.5 yrs.; Brain CT-scan shows in-
tracranial calcifications in the periventricular
white matter.
utics or radiotherapy. Focal or diffuse
EEG abnormalities with or without sei-
zures are usually associated with CNS
leukaemia9. Majority of patients with
ALL have normal EEG in hematological
remission prior to prophylactic cranial
irradiation6. Patients receiving MTX pa-
renterally very frequently revealed recur-
rent EEG abnormalities and less fre-
quently seizures as compared to the pa-
tients who were treated with CNS irra-
diation10. Improvement in EEG occurred
in 37% of ALL children 2 months after in-
troduction of chemotherapeutic treatment,
while EEG normalization was observed
in 65% of children after 1–1.5 years. Se-
vere persistent EEG abnormalities were
not registered in long-term follow up of
ALL children9. We observed persistent
EEG abnormalities 2–4 years after induc-
tion of clinical and hematological remis-
sion in children with ALL who received
CNS irradiation/methotrexate treatment.
Follow-up CT scans of reported chil-
dren revealed calcifications associated
with recurrent epileptic seizures and per-
sistent EEG abnormalities. According to
Medline there are no reports in the litera-
ture of intracranial calcifications associ-
ated with symptomatic epilepsy in ALL
children occurring in such a short period
after CNS irradiation and MTX treat-
ment. Ochs et al. studied 1,289 patients
with ALL, of whom 132 (10%) experi-
enced one or more seizures. CT scans
showed brain calcifications in 13 pa-
tients. But the period between irradiation
and MTX therapy and calcification in
brain was much longer than in our pa-
tients. Patients who received intrathecal
MTX repeatedly with or without MTX in-
travenously or prior to prophylactic cra-
nial irradiation had 20-fold higher sei-
zure risk during the 6th to 12th month of
therapy than those who received irradia-
tion and only five intrathecal injections of
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MTX early in the course of treatment11.
The lowest risk for seizure occurrence
was reported in patients with cranial ra-
diation with 2400 cGy and 5 MTX doses
according to the same protocol that was
applied in one of our patients (Case 1)11.
Seizures incidence is highest during in-
duction of antileukemic treatment, CNS
intensification and reinduction period.
Seizures were associated with cerebral le-
sions in 47% of ALL children12. Some au-
thors suggest the possibility that MTX
and CNS irradiation are primarily re-
sponsible for CNS abnormalities 1. Most
recently intracranial calcifications were
described in patients treated exclusively
with chemotherapy12,13. Parenteral appli-
cation of MTX or its vehicle may play an
important role in occurrence of seizures.
MTX interfere with folate and tetrahy-
drobiopterin metabolites causing a de-
crease in brain gamma-aminobutyric acid
(GABA) levels. Disruption of monoamine
metabolism on the rodent model has been
proposed as a cause of brain dysfunction
during MTX therapy. Seizure recurrence
was registered after multiple MTX injec-
tions correlating with high MTX doses
which might also be one of the reasons for
the development of late neurological se-
quels14,15. CNS irradiation damages the
blood brain barrier permitting MTX to
penetrate in the brain in larger amounts.
Especially high MTX levels are present in
patients with CNS leukemia (Case 1). We
did not observe intracranial calcifications




with symptomatic epilepsy might occur
as a late morphological and functional se-
quel of CNS leukemia itself or prophylac-
tic CNS irradiation together with intra-
thecal methotrexate treatment. EEG is
mostly normal in all children with ALL in
hematological and clinical remission,
showing transient abnormalities after
CNS irradiation. Longitudinal EEG as-
sessment of children with ALL treated
with intrathecal methotrexate and CNS
irradiation showed persistent abnormali-
ties clinically associated with epilepsy.
Combined prophylactic therapy of CNS
(MTX/irradiation), rather than MTX tre-
atment only, might be responsible for de-
velopment of brain calcifications result-
ing in seizures. However, the number of
our patients is far too small to make defi-
nite conclusions.
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SIMPTOMATSKA EPILEPSIJA POVEZANA S INTRAKRANIJALNIM
KALCIFIKACIJAMA U DJECE S AKUTNOM LIMFOBLASTI^NOM
LEUKEMIJOM (ALL)
S A @ E T A K
Akutne i dugotrajne posljedice profilakse sredi{njeg `iv~anog sustava (S@S) s iradi-
jacijom i intratekalnom kemoterapijom u djece koja boluju od akutne limfoblasti~ne
leukemije (ALL) uklju~uju: vaskulopatije, leukoencefalopatije, intrakranijalne kalcifi-
kacije, te intelektualne i neurolo{ke ispade. Izvje{}e je dano za dvoje djece, dobi 5 i 8
godina, kod kojih su se manifestirali djelomi~ni motorni ili kompleksni epilepti~ki na-
padi te intrakranijalne kalcifikacije 2–4 godine nakon {to je dijagnoza ALL utvr|ena.
Ovi poreme}aji javili su se mnogo ranije nego {to se mo`e na}i u literaturi. Oboje djece
primilo je profilakti~ku S@S terapiju s iradijacijom i intratekalnim metotrexatom
(MTX). Njihov CT pregled mozga i EEG bili su normalni prije nego {to je prvi epilepti-
~ki napad zabilje`en. Djeca su sada bez napada, na karbamazepinu, a dje~ak koji je
imao kompleksne djelomi~ne i miokloni~ke napade prima jo{ i valproat i vigabatrin.
Simptomatska epislepsija povezana s intrakranijalnim kalcifikacijama i postojanim
EEG promjenama mo`e se javiti kao uzgredna pojava lije~enja ALL.
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